Abstract:IgA nephropathy (IgAN) is the most common primary glomerulonephritis, frequently leading to end-stage renal disease, as there is no disease-specific therapy. IgAN is diagnosed from pathological assessment of a renal biopsy specimen based on predominant or codominant IgA-containing immunodeposits, usually with complement C3 co-deposits and with variable presence of IgG and/or IgM. The IgA in these renal deposits is galactose-deficient IgA1, with less than a full complement of galactose residues on the O-glycans in the hinge region of the heavy chains. Research from the past decade led to the definition of IgAN as an autoimmune disease with a multi-hit pathogenetic process with contributing genetic and environmental components. In this process, circulating galactose-deficient IgA1 (autoantigen) is bound by antiglycan IgG or IgA (autoantibodies) to form immune complexes. Some of these circulating complexes deposit in glomeruli, and thereby activate mesangial cells and induce renal injury through cellular proliferation and overproduction of extracellular matrix components and cytokines/chemokines. Glycosylation pathways associated with production of the autoantigen and the unique characteristics of the corresponding autoantibodies in patients with IgAN have been uncovered. Complement likely plays a significant role in the formation and the nephritogenic activities of these complexes. Complement activation is mediated through the alternative and lectin pathways and probably occurs systemically on IgA1-containing circulating immune complexes as well as locally in glomeruli. Incidence of IgAN varies greatly by geographical location; the disease is rare in central Africa but accounts for up to 40% of native-kidney biopsies in eastern Asia. Some of this variation may be explained by genetically determined influences on the pathogenesis of the disease. Genome-wide association studies to date have identified several loci associated with IgAN. Some of these loci are associated with the increased prevalence of IgAN, whereas others, such as deletion of complement factor H-related genes 1 and 3, are protective against the disease. Understanding the molecular mechanisms and genetic and biochemical factors involved in formation and activities of pathogenic IgA1-containing immune complexes will enable the development of future disease-specific therapies as well as identification of non-invasive disease-specific biomarkers.

Clinicopathological Analysis of IgA Nephropathy Combined with Other Glomerular Diseases

Clinical and Pathology Features of IgA Nephropathy with Active Tubular Interstitial Lesions

Clinical and Immunological Characteristics of Patients with Combined Anti-Glomerular Basement Membrane Disease and IgA Nephropathy.

The clinicopathologic characteristics of Immunoglobulin A nephropathy related to C3 deposits

Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.

Concurrent IgA nephropathy and membranous nephropathy, is it an overlap syndrome? (vol 13, 846323, 2022)

Clinicopathological Features of Antineutrophil Cytoplasmic Antibodies Associated Vasculitis with Glomerular IgA Deposits

The Clinicopathologic Characteristics and Complement Activation of Antineutrophil Cytoplasmic Antibody-associated Vasculitides with Glomerular IgA Deposition

Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN

Characterization of patients with IgA nephropathy with and without associated minimal change disease

Clinicopathologic Features of Membranous Nephropathy Coexisting with IgA Nephropathy

The study of the constitution, mucosal inflammation, Chinese medicine syndrome types and clinical pathology in IgA nephropathy

Clinical and pathological features in patients with different subtypes of IgA nephropathy

The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy

Clinical and Pathological Features of Immunoglobulin A Nephropathy with Antinuclear Antibodies

Concurrent membranous nephropathy and IgA nephropathy: a series of 55 cases

Glomerular C4 deposition and glomerulosclerosis predict worse renal outcomes in Chinese patients with IgA nephropathy

Coexistence of anti-glomerular basement membrane disease and IgA nephropathy: an illustrative case and comprehensive literature review

Clinical Implications of C2 Lesion in IgA Nephropathy: A Cohort Study

Clinical Significance of IgM and C3 Deposition in Children with Primary Immunoglobulin A Nephropathy.

Clinical and pathologic characteristics analysis of IgA nephropathy with malignant hypertension